Marcus Millichap Stock Performance
| MMI Stock | USD 40.58 0.45 1.12% |
Marcus Millichap has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.27, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Marcus Millichap will likely underperform. Marcus Millichap right now secures a risk of 1.78%. Please verify Marcus Millichap value at risk, as well as the relationship between the skewness and day median price , to decide if Marcus Millichap will be following its current price movements.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Marcus Millichap are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong primary indicators, Marcus Millichap is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 1.32 | Five Day Return (1.95) | Year To Date Return (4.93) | Ten Year Return 36.12 | All Time Return 202.98 |
Forward Dividend Yield 0.0125 | Payout Ratio 1.3514 | Forward Dividend Rate 0.5 | Dividend Date 2024-10-04 | Ex Dividend Date 2024-09-16 |
1 | Acquisition by Richard Matricaria of 2364 shares of Marcus Millichap subject to Rule 16b-3 | 09/04/2024 |
2 | Disposition of tradable shares by Kurt Schwarz of Marcus Millichap at 34.06 subject to Rule 16b-3 | 09/06/2024 |
3 | Disposition of 2110 shares by John Parker of Marcus Millichap at 34.06 subject to Rule 16b-3 | 09/09/2024 |
4 | Disposition of 30000 shares by Hessam Nadji of Marcus Millichap subject to Rule 16b-3 | 09/10/2024 |
5 | Disposition of 500 shares by Hessam Nadji of Marcus Millichap subject to Rule 16b-3 | 09/11/2024 |
6 | Disposition of 520 shares by Hessam Nadji of Marcus Millichap subject to Rule 16b-3 | 09/13/2024 |
7 | Marcus Millichap director sells over 44k in company stock | 09/17/2024 |
8 | Disposition of 1500 shares by Steven DeGennaro of Marcus Millichap subject to Rule 16b-3 | 09/27/2024 |
9 | Disposition of 469 shares by Hessam Nadji of Marcus Millichap subject to Rule 16b-3 | 09/30/2024 |
| Marcus Millichap dividend paid on 4th of October 2024 | 10/04/2024 |
10 | Metro Mining Limited Stock Catapults 26 percent Though Its Price And Business Still Lag The Industry | 10/11/2024 |
11 | Marcus Millichap Closes 101 Million 11-Property Hospitality Portfolio Sale | 10/21/2024 |
12 | Disposition of 117 shares by Kurt Schwarz of Marcus Millichap subject to Rule 16b-3 | 10/22/2024 |
13 | Marcus Millichap Inc Shares Up 3.01 percent on Oct 24 | 10/24/2024 |
14 | Morgan Stanley Wins Two 2024 Money Management Institute Barrons Industry Awards | 10/28/2024 |
15 | MMIs Symani Surgical System Named a TIME Best Invention of 2024 | 10/30/2024 |
16 | Marcus Millichaps IPA Capital Markets Arranges 63 Million Multifamily Refinance in Greater Austin | 11/07/2024 |
17 | Marcus Millichap earnings beat by 0.05, revenue fell short of estimates | 11/08/2024 |
18 | Disposition of 18400 shares by Hessam Nadji of Marcus Millichap subject to Rule 16b-3 | 11/11/2024 |
19 | MMIs robotic technology to support lymphatic surgery at TGH | 11/18/2024 |
| Begin Period Cash Flow | 235.9 M |
Marcus |
Marcus Millichap Relative Risk vs. Return Landscape
If you would invest 3,985 in Marcus Millichap on August 24, 2024 and sell it today you would earn a total of 73.00 from holding Marcus Millichap or generate 1.83% return on investment over 90 days. Marcus Millichap is generating 0.0443% of daily returns assuming volatility of 1.7812% on return distribution over 90 days investment horizon. In other words, 15% of stocks are less volatile than Marcus, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Marcus Millichap Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Marcus Millichap's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Marcus Millichap, and traders can use it to determine the average amount a Marcus Millichap's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0249
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MMI |
Estimated Market Risk
| 1.78 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Marcus Millichap is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Marcus Millichap by adding it to a well-diversified portfolio.
Marcus Millichap Fundamentals Growth
Marcus Stock prices reflect investors' perceptions of the future prospects and financial health of Marcus Millichap, and Marcus Millichap fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Marcus Stock performance.
| Return On Equity | -0.0492 | ||||
| Return On Asset | -0.0415 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 1.34 B | ||||
| Shares Outstanding | 38.82 M | ||||
| Price To Earning | 33.97 X | ||||
| Price To Book | 2.52 X | ||||
| Price To Sales | 2.50 X | ||||
| Revenue | 645.93 M | ||||
| Gross Profit | 450.82 M | ||||
| EBITDA | (44.22 M) | ||||
| Net Income | (34.03 M) | ||||
| Cash And Equivalents | 235.87 M | ||||
| Cash Per Share | 11.63 X | ||||
| Total Debt | 87.74 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.89 X | ||||
| Book Value Per Share | 15.92 X | ||||
| Cash Flow From Operations | (72.43 M) | ||||
| Earnings Per Share | (0.81) X | ||||
| Market Capitalization | 1.56 B | ||||
| Total Asset | 878.41 M | ||||
| Retained Earnings | 492.3 M | ||||
| Working Capital | 288.43 M | ||||
| Current Asset | 196.11 M | ||||
| Current Liabilities | 75.01 M | ||||
About Marcus Millichap Performance
By evaluating Marcus Millichap's fundamental ratios, stakeholders can gain valuable insights into Marcus Millichap's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Marcus Millichap has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Marcus Millichap has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 4.27 | 4.06 | |
| Return On Tangible Assets | (0.04) | (0.04) | |
| Return On Capital Employed | (0.08) | (0.07) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.05) | (0.05) |
Things to note about Marcus Millichap performance evaluation
Checking the ongoing alerts about Marcus Millichap for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Marcus Millichap help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the last year's revenue of 645.93 M. Reported Net Loss for the year was (34.03 M) with profit before taxes, overhead, and interest of 450.82 M. | |
| Marcus Millichap has about 235.87 M in cash with (72.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.63. | |
| Marcus Millichap has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| On 4th of October 2024 Marcus Millichap paid $ 0.25 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: MMIs robotic technology to support lymphatic surgery at TGH |
- Analyzing Marcus Millichap's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Marcus Millichap's stock is overvalued or undervalued compared to its peers.
- Examining Marcus Millichap's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Marcus Millichap's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Marcus Millichap's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Marcus Millichap's stock. These opinions can provide insight into Marcus Millichap's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Marcus Stock analysis
When running Marcus Millichap's price analysis, check to measure Marcus Millichap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marcus Millichap is operating at the current time. Most of Marcus Millichap's value examination focuses on studying past and present price action to predict the probability of Marcus Millichap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marcus Millichap's price. Additionally, you may evaluate how the addition of Marcus Millichap to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |